Rethinking Opioid Conversions: Mary Lynn McPherson and Drew Rosielle
GeriPal
MAY 19, 2022
And really, the best that had ever been looked at, especially in our population and sort of a cancer serious illness population. But I think people would have an embolic event if you gave them a flipping range. And then again, individualizing it to the patient. Eric: Drew, both of our fourth step is individualizing it.
Let's personalize your content